BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34851737)

  • 21. Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer.
    Tcyganov EN; Hanabuchi S; Hashimoto A; Campbell D; Kar G; Slidel TW; Cayatte C; Landry A; Pilataxi F; Hayes S; Dougherty B; Hicks KC; Mulgrew K; Tang CA; Hu CA; Guo W; Grivennikov S; Ali MA; Beltra JC; Wherry EJ; Nefedova Y; Gabrilovich DI
    J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.
    Pyzer AR; Stroopinsky D; Rajabi H; Washington A; Tagde A; Coll M; Fung J; Bryant MP; Cole L; Palmer K; Somaiya P; Karp Leaf R; Nahas M; Apel A; Jain S; McMasters M; Mendez L; Levine J; Joyce R; Arnason J; Pandolfi PP; Kufe D; Rosenblatt J; Avigan D
    Blood; 2017 Mar; 129(13):1791-1801. PubMed ID: 28126925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
    Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
    Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals.
    Qin A; Cai W; Pan T; Wu K; Yang Q; Wang N; Liu Y; Yan D; Hu F; Guo P; Chen X; Chen L; Zhang H; Tang X; Zhou J
    J Virol; 2013 Feb; 87(3):1477-90. PubMed ID: 23152536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulatory effects of myeloid-derived suppressor cells in diseases: Role in cancer and infections.
    Tamadaho RSE; Hoerauf A; Layland LE
    Immunobiology; 2018; 223(4-5):432-442. PubMed ID: 29246400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response
    Liu L; Lin Q; Peng J; Fang J; Tan Z; Tang H; Kwan K; Nishiura K; Liang J; Kwok H; Du Z; Sun J; Liu K; Yuen KY; Wang H; Chen Z
    EBioMedicine; 2020 Oct; 60():103008. PubMed ID: 32979832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine.
    Yaseen MM; Abuharfeil NM; Darmani H; Daoud A
    Open Biol; 2020 Sep; 10(9):200111. PubMed ID: 32931721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the origin of myeloid-derived suppressor cells.
    Millrud CR; Bergenfelz C; Leandersson K
    Oncotarget; 2017 Jan; 8(2):3649-3665. PubMed ID: 27690299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against
    Gamba JC; Roldán C; Prochetto E; Lupi G; Bontempi I; Poncini CV; Vermeulen M; Pérez AR; Marcipar I; Cabrera G
    Front Cell Infect Microbiol; 2021; 11():671104. PubMed ID: 34295832
    [No Abstract]   [Full Text] [Related]  

  • 30. Myeloid-Derived Suppressor Cells in Lung Transplantation.
    Heigl T; Singh A; Saez-Gimenez B; Kaes J; Van Herck A; Sacreas A; Beeckmans H; Vanstapel A; Verleden SE; Van Raemdonck DE; Verleden G; Vanaudenaerde BM; Hartl D; Vos R
    Front Immunol; 2019; 10():900. PubMed ID: 31080450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.
    Garg A; Spector SA
    J Infect Dis; 2014 Feb; 209(3):441-51. PubMed ID: 23999600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis.
    Uhel F; Azzaoui I; Grégoire M; Pangault C; Dulong J; Tadié JM; Gacouin A; Camus C; Cynober L; Fest T; Le Tulzo Y; Roussel M; Tarte K
    Am J Respir Crit Care Med; 2017 Aug; 196(3):315-327. PubMed ID: 28146645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of myeloid derived suppressor cells in sepsis.
    Malavika M; Sanju S; Poorna MR; Vishnu Priya V; Sidharthan N; Varma P; Mony U
    Int Immunopharmacol; 2022 Mar; 104():108452. PubMed ID: 34996010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocytic Myeloid-Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level.
    Tumino N; Bilotta MT; Pinnetti C; Ammassari A; Antinori A; Turchi F; Agrati C; Casetti R; Bordoni V; Cimini E; Abbate I; Capobianchi MR; Martini F; Sacchi A
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):575-582. PubMed ID: 28060224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Antimicrobial Activity of Monocytic Myeloid-Derived Suppressor Cells in Infection with Mycobacterium tuberculosis and Human Immunodeficiency Virus.
    Garg A
    Methods Mol Biol; 2021; 2236():115-127. PubMed ID: 33237545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer.
    Sasidharan Nair V; Saleh R; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Alajez NM; Abu Nada M; Elkord E
    Clin Epigenetics; 2020 Jan; 12(1):13. PubMed ID: 31941522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications.
    Xing YF; Cai RM; Lin Q; Ye QJ; Ren JH; Yin LH; Li X
    Kidney Int; 2017 May; 91(5):1236-1242. PubMed ID: 28215666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
    Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
    Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A
    Yang Q; Qiu H; Xie H; Qi Y; Cha H; Qu J; Wang M; Feng Y; Ye X; Mu J; Huang J
    J Immunol; 2017 Jun; 198(12):4716-4727. PubMed ID: 28476935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.